🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial investigates the efficacy and safety of brodalumab against guselk...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2020-12-17
Trial ID
NCT04533737
Treatments Being Tested
The purpose of this study is to investigate the effect on the frequency of ...
Status
Withdrawn
Location
US010
Start Date
2015-03
Trial ID
NCT02174094
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate S...
Status
Completed
Location
KEMRI/Centre for Respiratory Diseases Research Siaya Clinical Research Annex
Start Date
2023-10-19
Trial ID
NCT05817422
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
This clinical study is a randomized, double-blind, double-dummy, parallel g...
Status
Suspended
Location
Sun City Clinical Research
Start Date
2022-12-14
Trial ID
NCT05324358
Treatments Being Tested
Neurocognitive complications, mainly delirium and neurocognitive disorders,...
Status
Not Yet Recruiting
Location
Peking University First Hospital
Start Date
2026-06
Trial ID
NCT07576517
Treatments Being Tested
All enrolled participants will be randomized to 3 cohorts with 8 participan...
Status
Completed
Location
Universität Basel Departement Klinische Forschung Ambulantes Studienzentrum
Start Date
2023-03-28
Trial ID
NCT05848453
Treatments Being Tested
The goal of this clinical trial is to explore Clinical Effect of Glossophar...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT06328205
Treatments Being Tested